Biotricity Total Debt vs Accumulated Retained Earnings Deficit Analysis

BTCY Stock  USD 1.36  0.03  2.26%   
Trend analysis of Biotricity balance sheet accounts such as Short Long Term Debt Total of 23.6 M, Other Current Liabilities of 3.2 M or Total Current Liabilities of 13.5 M provides information on Biotricity's total assets, liabilities, and equity, which is the actual value of Biotricity to its prevalent stockholders. By breaking down trends over time using Biotricity balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.

About Biotricity Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biotricity at a specified time, usually calculated after every quarter, six months, or one year. Biotricity Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biotricity and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biotricity currently owns. An asset can also be divided into two categories, current and non-current.

Biotricity Balance Sheet Chart

Biotricity Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biotricity uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Biotricity's Other Stockholder Equity is fairly stable compared to the past year. Total Liabilities is likely to rise to about 31.8 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (17 M).

Total Assets

Total assets refers to the total amount of Biotricity assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biotricity books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biotricity balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biotricity are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Biotricity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biotricity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.Selling General Administrative is likely to rise to about 21.3 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 2.2 M in 2024.

Biotricity fundamental ratios Correlations

0.780.550.6-0.490.610.53-0.810.570.820.820.890.580.280.80.820.760.970.570.7-0.30.760.610.750.660.62
0.780.650.88-0.90.720.94-0.930.950.30.30.90.60.340.990.950.990.620.880.74-0.260.990.960.780.750.97
0.550.650.89-0.710.620.6-0.740.660.220.220.790.660.240.580.720.730.470.840.67-0.830.560.570.50.610.6
0.60.880.89-0.930.770.88-0.90.920.10.10.870.70.310.820.90.930.440.990.77-0.620.830.870.690.770.87
-0.49-0.9-0.71-0.93-0.67-0.970.85-0.970.070.07-0.75-0.58-0.3-0.86-0.84-0.93-0.31-0.94-0.690.38-0.89-0.94-0.68-0.69-0.95
0.610.720.620.77-0.670.65-0.880.760.260.260.770.90.330.680.890.750.50.810.89-0.490.690.70.70.810.67
0.530.940.60.88-0.970.65-0.830.98-0.04-0.040.750.490.30.920.850.950.330.90.63-0.210.940.980.660.690.99
-0.81-0.93-0.74-0.90.85-0.88-0.83-0.89-0.4-0.4-0.94-0.82-0.37-0.9-0.99-0.94-0.7-0.9-0.910.48-0.9-0.86-0.86-0.84-0.86
0.570.950.660.92-0.970.760.98-0.890.020.020.790.630.320.920.910.960.380.940.74-0.320.940.980.720.740.98
0.820.30.220.10.070.26-0.04-0.40.021.00.530.330.120.350.390.260.920.050.39-0.180.270.060.430.290.07
0.820.30.220.10.070.26-0.04-0.40.021.00.530.330.120.350.390.260.920.050.39-0.180.270.060.430.290.07
0.890.90.790.87-0.750.770.75-0.940.790.530.530.70.330.860.950.910.80.850.8-0.510.860.790.80.850.8
0.580.60.660.7-0.580.90.49-0.820.630.330.330.70.490.580.790.640.550.710.97-0.630.560.540.720.70.52
0.280.340.240.31-0.30.330.3-0.370.320.120.120.330.490.330.350.340.240.320.49-0.090.330.330.330.30.32
0.80.990.580.82-0.860.680.92-0.90.920.350.350.860.580.330.930.970.650.820.73-0.20.990.930.760.710.95
0.820.950.720.9-0.840.890.85-0.990.910.390.390.950.790.350.930.960.690.910.88-0.440.930.890.830.860.89
0.760.990.730.93-0.930.750.95-0.940.960.260.260.910.640.340.970.960.60.930.77-0.370.970.960.780.780.97
0.970.620.470.44-0.310.50.33-0.70.380.920.920.80.550.240.650.690.60.410.66-0.30.590.410.70.550.43
0.570.880.840.99-0.940.810.9-0.90.940.050.050.850.710.320.820.910.930.410.77-0.570.850.90.720.780.89
0.70.740.670.77-0.690.890.63-0.910.740.390.390.80.970.490.730.880.770.660.77-0.550.710.670.830.740.66
-0.3-0.26-0.83-0.620.38-0.49-0.210.48-0.32-0.18-0.18-0.51-0.63-0.09-0.2-0.44-0.37-0.3-0.57-0.55-0.18-0.21-0.36-0.47-0.19
0.760.990.560.83-0.890.690.94-0.90.940.270.270.860.560.330.990.930.970.590.850.71-0.180.970.790.730.97
0.610.960.570.87-0.940.70.98-0.860.980.060.060.790.540.330.930.890.960.410.90.67-0.210.970.750.740.99
0.750.780.50.69-0.680.70.66-0.860.720.430.430.80.720.330.760.830.780.70.720.83-0.360.790.750.760.7
0.660.750.610.77-0.690.810.69-0.840.740.290.290.850.70.30.710.860.780.550.780.74-0.470.730.740.760.7
0.620.970.60.87-0.950.670.99-0.860.980.070.070.80.520.320.950.890.970.430.890.66-0.190.970.990.70.7
Click cells to compare fundamentals

Biotricity Account Relationship Matchups

Biotricity fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets2.0M4.4M16.7M6.5M7.5M7.9M
Short Long Term Debt Total2.3M4.7M15.4M19.5M22.5M23.6M
Other Current Liab427.6K5.1M2.0M2.6M3.0M3.2M
Total Current Liabilities3.8M10.5M4.9M11.2M12.8M13.5M
Total Stockholder Equity(3.0M)(6.8M)(2.1M)(19.8M)(17.9M)(17.0M)
Net Debt1.4M2.5M3.3M19.0M21.8M22.9M
Retained Earnings(46.4M)(62.8M)(93.0M)(112.6M)(101.3M)(96.2M)
Accounts Payable1.1M1.0M1.2M3.4M4.0M4.1M
Cash949.8K2.2M12.1M570.5K656.0K623.2K
Cash And Short Term Investments949.8K2.2M12.1M570.5K656.0K623.2K
Net Receivables623.3K1.8M2.4M1.8M2.1M2.2M
Common Stock Total Equity31.9K35.4K36.4K39.0K44.9K27.8K
Common Stock Shares Outstanding6.0M6.3M7.6M8.7M10.0M7.3M
Liabilities And Stockholders Equity2.0M4.4M16.7M6.5M7.5M7.9M
Non Current Liabilities Total1.2M780.9K14.0M15.2M17.5M18.3M
Other Stockholder Equity88.4M113.2M183.2M185.7M213.5M224.2M
Total Liab5.0M11.3M18.8M26.4M30.3M31.8M
Total Current Assets1.7M4.3M15.3M4.7M5.4M3.2M
Accumulated Other Comprehensive Income(857.3K)(634.2K)(768.7K)(152.8K)(137.5K)(144.4K)
Short Term Debt2.3M4.3M1.8M5.1M5.9M6.2M
Common Stock36.4K39.0K51.3K52.5K60.4K33.8K
Net Tangible Assets(1.8M)(3.0M)(6.8M)(2.1M)(1.9M)(2.0M)
Non Current Assets Total345.6K116.5K1.4M1.8M2.1M2.2M
Non Currrent Assets Other81.1K50.4K85K181.3K208.5K219.0K
Inventory85.7K272.5K842.9K2.3M2.7M2.8M
Other Current Assets137.1K326.7K406.3K588.6M676.9M710.7M
Short Long Term Debt2.1M4.3M1.5M4.8M5.5M5.8M
Net Invested Capital(932.1K)(2.2M)11.9M(2.0M)(2.3M)(2.2M)
Net Working Capital(2.1M)(6.2M)10.5M(6.4M)(5.8M)(5.5M)
Capital Stock36.4K39.0K51.3K52.5K60.4K47.2K

Pair Trading with Biotricity

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotricity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will appreciate offsetting losses from the drop in the long position's value.

Moving against Biotricity Stock

  0.71MMSI Merit Medical Systems Financial Report 24th of April 2024 PairCorr
  0.54TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.53AHG Akso Health GroupPairCorr
  0.51SSY SunLink Health SystemsPairCorr
The ability to find closely correlated positions to Biotricity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotricity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotricity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotricity to buy it.
The correlation of Biotricity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotricity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotricity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotricity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Biotricity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biotricity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biotricity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biotricity Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotricity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
For more information on how to buy Biotricity Stock please use our How to Invest in Biotricity guide.
Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Biotricity Stock analysis

When running Biotricity's price analysis, check to measure Biotricity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotricity is operating at the current time. Most of Biotricity's value examination focuses on studying past and present price action to predict the probability of Biotricity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotricity's price. Additionally, you may evaluate how the addition of Biotricity to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Biotricity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biotricity. If investors know Biotricity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biotricity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
1.319
Quarterly Revenue Growth
0.209
Return On Assets
(0.95)
Return On Equity
(41.01)
The market value of Biotricity is measured differently than its book value, which is the value of Biotricity that is recorded on the company's balance sheet. Investors also form their own opinion of Biotricity's value that differs from its market value or its book value, called intrinsic value, which is Biotricity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biotricity's market value can be influenced by many factors that don't directly affect Biotricity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biotricity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotricity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotricity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.